Pancreatic Cancer Research

Clinical trialObsCompleted

Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan

Survival Rate and Treatment Cost in Patients With Pancreatic Cancer With the Advent of New Chemotherapeutic Agents in Korea: An Analysis Using NHIS Database and K-PaC Registry Focusing on the Newest One, Liposomal Irinotecan

NCT04984174↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Finished, no results posted
Phase
Obs
Status
Completed
Study type
Observational
Start
4 August 2021
Expected end
28 December 2024
Enrollment
14,760 participants
Sites
1
Primary outcomes
Cost-effectiveness analysis of chemotherapy; age, sex, types of institutions and chemotherapy regimens
Sponsor
Other gov
Results posted
No
Last update
18 June 2025

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 7